Trial Profile
Clinical pilot study to review the impact of perioperative administration of the synthetic cannabinoid nabilone in the context of spinal fusion surgery on the coping with surgery and the pain perception of patients with severely reduced quality of life.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2020
Price :
$35
*
At a glance
- Drugs Nabilone (Primary)
- Indications Pain
- Focus Therapeutic Use
- 24 Apr 2020 Status changed from recruiting to completed.
- 12 Jul 2016 New trial record